EMEA (Europe, Middle East and Africa) Chronic Urticaria Or Hives Drug Market Report 2018

February 2018 | 118 pages | ID: E2815C0DC2EEN
QYResearch

Abstracts

In this report, the EMEA Chronic Urticaria Or Hives Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Chronic Urticaria Or Hives Drug for these regions, from 2013 to 2025 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Chronic Urticaria Or Hives Drug market competition by top manufacturers/players, with Chronic Urticaria Or Hives Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca Plc
• Biofrontera AG
• ELORAC, Inc.
• Faes Farma, SA
• Genentech, Inc.
• GlaxoSmithKline Plc
• J Uriach Y Compania, S.A.
• Mabtech Limited
• Merck & Co., Inc.
• Mycenax Biotech Inc.
• Novartis AG
• Panacea Biotec Limited

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• GDC-0853
• GSK-2646264
• BF-Derm-1
• Bilastine
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Clinic
• Hospital
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Chronic Urticaria Or Hives Drug Market Report 2018

1 CHRONIC URTICARIA OR HIVES DRUG OVERVIEW

1.1 Product Overview and Scope of Chronic Urticaria Or Hives Drug
1.2 Classification of Chronic Urticaria Or Hives Drug
  1.2.1 EMEA Chronic Urticaria Or Hives Drug Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Chronic Urticaria Or Hives Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 GDC-0853
  1.2.4 GSK-2646264
  1.2.5 BF-Derm-1
  1.2.6 Bilastine
  1.2.7 Others
1.3 EMEA Chronic Urticaria Or Hives Drug Market by Application/End Users
  1.3.1 EMEA Chronic Urticaria Or Hives Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 EMEA Chronic Urticaria Or Hives Drug Market by Region
  1.4.1 EMEA Chronic Urticaria Or Hives Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Chronic Urticaria Or Hives Drug (2013-2025)
  1.5.1 EMEA Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2013-2025)

2 EMEA CHRONIC URTICARIA OR HIVES DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Chronic Urticaria Or Hives Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Chronic Urticaria Or Hives Drug Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Chronic Urticaria Or Hives Drug Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Chronic Urticaria Or Hives Drug Sale Price by Players (2013-2018)
2.2 EMEA Chronic Urticaria Or Hives Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Chronic Urticaria Or Hives Drug Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Chronic Urticaria Or Hives Drug Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Chronic Urticaria Or Hives Drug Sale Price by Type (2013-2018)
2.3 EMEA Chronic Urticaria Or Hives Drug (Volume) by Application
2.4 EMEA Chronic Urticaria Or Hives Drug (Volume and Value) by Region
  2.4.1 EMEA Chronic Urticaria Or Hives Drug Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Chronic Urticaria Or Hives Drug Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Chronic Urticaria Or Hives Drug Sales Price by Region (2013-2018)

3 EUROPE CHRONIC URTICARIA OR HIVES DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Chronic Urticaria Or Hives Drug Sales and Value (2013-2018)
  3.1.1 Europe Chronic Urticaria Or Hives Drug Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2013-2018)
3.2 Europe Chronic Urticaria Or Hives Drug Sales and Market Share by Type
3.3 Europe Chronic Urticaria Or Hives Drug Sales and Market Share by Application
3.4 Europe Chronic Urticaria Or Hives Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Chronic Urticaria Or Hives Drug Sales Volume by Countries (2013-2018)
  3.4.2 Europe Chronic Urticaria Or Hives Drug Revenue by Countries (2013-2018)
  3.4.3 Germany Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2018)
  3.4.4 France Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2018)
  3.4.5 UK Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2018)
  3.4.6 Russia Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2018)
  3.4.7 Italy Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2018)

4 MIDDLE EAST CHRONIC URTICARIA OR HIVES DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Chronic Urticaria Or Hives Drug Sales and Value (2013-2018)
  4.1.1 Middle East Chronic Urticaria Or Hives Drug Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2013-2018)
4.2 Middle East Chronic Urticaria Or Hives Drug Sales and Market Share by Type
4.3 Middle East Chronic Urticaria Or Hives Drug Sales and Market Share by Application
4.4 Middle East Chronic Urticaria Or Hives Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Chronic Urticaria Or Hives Drug Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Chronic Urticaria Or Hives Drug Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2018)
  4.4.4 Israel Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2018)
  4.4.5 UAE Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2018)
  4.4.6 Iran Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2018)

5 AFRICA CHRONIC URTICARIA OR HIVES DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Chronic Urticaria Or Hives Drug Sales and Value (2013-2018)
  5.1.1 Africa Chronic Urticaria Or Hives Drug Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2013-2018)
5.2 Africa Chronic Urticaria Or Hives Drug Sales and Market Share by Type
5.3 Africa Chronic Urticaria Or Hives Drug Sales and Market Share by Application
5.4 Africa Chronic Urticaria Or Hives Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Chronic Urticaria Or Hives Drug Sales Volume by Countries (2013-2018)
  5.4.2 Africa Chronic Urticaria Or Hives Drug Revenue by Countries (2013-2018)
  5.4.3 South Africa Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Chronic Urticaria Or Hives Drug Sales and Growth Rate (2013-2018)

6 EMEA CHRONIC URTICARIA OR HIVES DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AstraZeneca Plc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Chronic Urticaria Or Hives Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Biofrontera AG
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Chronic Urticaria Or Hives Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 ELORAC, Inc.
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Chronic Urticaria Or Hives Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Faes Farma, SA
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Chronic Urticaria Or Hives Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Genentech, Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Chronic Urticaria Or Hives Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline Plc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Chronic Urticaria Or Hives Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 J Uriach Y Compania, S.A.
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Chronic Urticaria Or Hives Drug Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Mabtech Limited
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Chronic Urticaria Or Hives Drug Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Merck & Co., Inc.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Chronic Urticaria Or Hives Drug Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Mycenax Biotech Inc.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Chronic Urticaria Or Hives Drug Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Novartis AG
6.12 Panacea Biotec Limited

7 CHRONIC URTICARIA OR HIVES DRUG MANUFACTURING COST ANALYSIS

7.1 Chronic Urticaria Or Hives Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Chronic Urticaria Or Hives Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Chronic Urticaria Or Hives Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Chronic Urticaria Or Hives Drug Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA CHRONIC URTICARIA OR HIVES DRUG MARKET FORECAST (2018-2025)

11.1 EMEA Chronic Urticaria Or Hives Drug Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Chronic Urticaria Or Hives Drug Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Chronic Urticaria Or Hives Drug Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Chronic Urticaria Or Hives Drug Price and Trend Forecast (2018-2025)
11.2 EMEA Chronic Urticaria Or Hives Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Chronic Urticaria Or Hives Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Chronic Urticaria Or Hives Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Chronic Urticaria Or Hives Drug Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Chronic Urticaria Or Hives Drug Sales Forecast by Type (2018-2025)
11.7 EMEA Chronic Urticaria Or Hives Drug Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Chronic Urticaria Or Hives Drug
Figure EMEA Chronic Urticaria Or Hives Drug Sales Volume (K Pcs) by Type (2013-2025)
Figure EMEA Chronic Urticaria Or Hives Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure GDC-0853 Product Picture
Figure GSK-2646264 Product Picture
Figure BF-Derm-1 Product Picture
Figure Bilastine Product Picture
Figure Others Product Picture
Figure EMEA Chronic Urticaria Or Hives Drug Sales Volume (K Pcs) by Application (2013-2025)
Figure EMEA Sales Market Share of Chronic Urticaria Or Hives Drug by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Chronic Urticaria Or Hives Drug Market Size (Million USD) by Region (2013-2025)
Figure Europe Chronic Urticaria Or Hives Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Chronic Urticaria Or Hives Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Chronic Urticaria Or Hives Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Chronic Urticaria Or Hives Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Chronic Urticaria Or Hives Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Chronic Urticaria Or Hives Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Chronic Urticaria Or Hives Drug Sales Volume and Growth Rate (2013-2025)
Figure EMEA Chronic Urticaria Or Hives Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Chronic Urticaria Or Hives Drug Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table EMEA Chronic Urticaria Or Hives Drug Sales Volume (K Pcs) of Major Players (2013-2018)
Table EMEA Chronic Urticaria Or Hives Drug Sales Share by Players (2013-2018)
Figure 2017 Chronic Urticaria Or Hives Drug Sales Share by Players
Figure 2017 Chronic Urticaria Or Hives Drug Sales Share by Players
Figure EMEA Chronic Urticaria Or Hives Drug Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Chronic Urticaria Or Hives Drug Revenue (Million USD) by Players (2013-2018)
Table EMEA Chronic Urticaria Or Hives Drug Revenue Share by Players (2013-2018)
Table 2017 EMEA Chronic Urticaria Or Hives Drug Revenue Share by Players
Table 2017 EMEA Chronic Urticaria Or Hives Drug Revenue Share by Players
Table EMEA Chronic Urticaria Or Hives Drug Sale Price (USD/Pcs) by Players (2013-2018)
Table EMEA Chronic Urticaria Or Hives Drug Sales (K Pcs) and Market Share by Type (2013-2018)
Table EMEA Chronic Urticaria Or Hives Drug Sales Share by Type (2013-2018)
Figure Sales Market Share of Chronic Urticaria Or Hives Drug by Type (2013-2018)
Figure EMEA Chronic Urticaria Or Hives Drug Sales Market Share by Type (2013-2018)
Table EMEA Chronic Urticaria Or Hives Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Chronic Urticaria Or Hives Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Chronic Urticaria Or Hives Drug by Type in 2017
Table EMEA Chronic Urticaria Or Hives Drug Sale Price (USD/Pcs) by Type (2013-2018)
Table EMEA Chronic Urticaria Or Hives Drug Sales (K Pcs) and Market Share by Application (2013-2018)
Table EMEA Chronic Urticaria Or Hives Drug Sales Share by Application (2013-2018)
Figure Sales Market Share of Chronic Urticaria Or Hives Drug by Application (2013-2018)
Figure EMEA Chronic Urticaria Or Hives Drug Sales Market Share by Application in 2017
Table EMEA Chronic Urticaria Or Hives Drug Sales (K Pcs) and Market Share by Region (2013-2018)
Table EMEA Chronic Urticaria Or Hives Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Chronic Urticaria Or Hives Drug by Region (2013-2018)
Figure EMEA Chronic Urticaria Or Hives Drug Sales Market Share in 2017
Table EMEA Chronic Urticaria Or Hives Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Chronic Urticaria Or Hives Drug Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Chronic Urticaria Or Hives Drug by Region (2013-2018)
Figure EMEA Chronic Urticaria Or Hives Drug Revenue Market Share Regions in 2017
Table EMEA Chronic Urticaria Or Hives Drug Sales Price (USD/Pcs) by Region (2013-2018)
Figure Europe Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Chronic Urticaria Or Hives Drug Revenue and Growth Rate (2013-2018)
Table Europe Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2013-2018)
Table Europe Chronic Urticaria Or Hives Drug Market Share by Type (2013-2018)
Figure Europe Chronic Urticaria Or Hives Drug Market Share by Type in 2017
Table Europe Chronic Urticaria Or Hives Drug Sales (K Pcs) by Application (2013-2018)
Table Europe Chronic Urticaria Or Hives Drug Market Share by Application (2013-2018)
Figure Europe Chronic Urticaria Or Hives Drug Market Share by Application in 2017
Table Europe Chronic Urticaria Or Hives Drug Sales (K Pcs) by Countries (2013-2018)
Table Europe Chronic Urticaria Or Hives Drug Sales Market Share by Countries (2013-2018)
Figure Europe Chronic Urticaria Or Hives Drug Sales Market Share by Countries (2013-2018)
Figure Europe Chronic Urticaria Or Hives Drug Sales Market Share by Countries in 2017
Table Europe Chronic Urticaria Or Hives Drug Revenue (Million USD) by Countries (2013-2018)
Table Europe Chronic Urticaria Or Hives Drug Revenue Market Share by Countries (2013-2018)
Figure Europe Chronic Urticaria Or Hives Drug Revenue Market Share by Countries (2013-2018)
Figure Europe Chronic Urticaria Or Hives Drug Revenue Market Share by Countries in 2017
Figure Germany Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure France Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure UK Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Russia Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Italy Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Benelux Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Middle East Chronic Urticaria Or Hives Drug Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2013-2018)
Table Middle East Chronic Urticaria Or Hives Drug Market Share by Type (2013-2018)
Figure Middle East Chronic Urticaria Or Hives Drug Market Share by Type (2013-2018)
Table Middle East Chronic Urticaria Or Hives Drug Sales (K Pcs) by Applications (2013-2018)
Table Middle East Chronic Urticaria Or Hives Drug Market Share by Applications (2013-2018)
Figure Middle East Chronic Urticaria Or Hives Drug Sales Market Share by Application in 2017
Table Middle East Chronic Urticaria Or Hives Drug Sales Volume (K Pcs) by Countries (2013-2018)
Table Middle East Chronic Urticaria Or Hives Drug Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Chronic Urticaria Or Hives Drug Sales Volume Market Share by Countries in 2017
Table Middle East Chronic Urticaria Or Hives Drug Revenue (Million USD) by Countries (2013-2018)
Table Middle East Chronic Urticaria Or Hives Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East Chronic Urticaria Or Hives Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East Chronic Urticaria Or Hives Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Israel Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure UAE Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Iran Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Africa Chronic Urticaria Or Hives Drug Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Chronic Urticaria Or Hives Drug Sales (K Pcs) by Type (2013-2018)
Table Africa Chronic Urticaria Or Hives Drug Sales Market Share by Type (2013-2018)
Figure Africa Chronic Urticaria Or Hives Drug Sales Market Share by Type (2013-2018)
Figure Africa Chronic Urticaria Or Hives Drug Sales Market Share by Type in 2017
Table Africa Chronic Urticaria Or Hives Drug Sales (K Pcs) by Application (2013-2018)
Table Africa Chronic Urticaria Or Hives Drug Sales Market Share by Application (2013-2018)
Figure Africa Chronic Urticaria Or Hives Drug Sales Market Share by Application (2013-2018)
Table Africa Chronic Urticaria Or Hives Drug Sales Volume (K Pcs) by Countries (2013-2018)
Table Africa Chronic Urticaria Or Hives Drug Sales Market Share by Countries (2013-2018)
Figure Africa Chronic Urticaria Or Hives Drug Sales Market Share by Countries (2013-2018)
Figure Africa Chronic Urticaria Or Hives Drug Sales Market Share by Countries in 2017
Table Africa Chronic Urticaria Or Hives Drug Revenue (Million USD) by Countries (2013-2018)
Table Africa Chronic Urticaria Or Hives Drug Revenue Market Share by Countries (2013-2018)
Figure Africa Chronic Urticaria Or Hives Drug Revenue Market Share by Countries (2013-2018)
Figure Africa Chronic Urticaria Or Hives Drug Revenue Market Share by Countries in 2017
Figure South Africa Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Nigeria Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Egypt Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Algeria Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Table AstraZeneca Plc Chronic Urticaria Or Hives Drug Basic Information List
Table AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure AstraZeneca Plc Chronic Urticaria Or Hives Drug Sales Market Share in EMEA (2013-2018)
Figure AstraZeneca Plc Chronic Urticaria Or Hives Drug Revenue Market Share in EMEA (2013-2018)
Table Biofrontera AG Chronic Urticaria Or Hives Drug Basic Information List
Table Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Biofrontera AG Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Biofrontera AG Chronic Urticaria Or Hives Drug Sales Market Share in EMEA (2013-2018)
Figure Biofrontera AG Chronic Urticaria Or Hives Drug Revenue Market Share in EMEA (2013-2018)
Table ELORAC, Inc. Chronic Urticaria Or Hives Drug Basic Information List
Table ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure ELORAC, Inc. Chronic Urticaria Or Hives Drug Sales Market Share in EMEA (2013-2018)
Figure ELORAC, Inc. Chronic Urticaria Or Hives Drug Revenue Market Share in EMEA (2013-2018)
Table Faes Farma, SA Chronic Urticaria Or Hives Drug Basic Information List
Table Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Faes Farma, SA Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Faes Farma, SA Chronic Urticaria Or Hives Drug Sales Market Share in EMEA (2013-2018)
Figure Faes Farma, SA Chronic Urticaria Or Hives Drug Revenue Market Share in EMEA (2013-2018)
Table Genentech, Inc. Chronic Urticaria Or Hives Drug Basic Information List
Table Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Genentech, Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Genentech, Inc. Chronic Urticaria Or Hives Drug Sales Market Share in EMEA (2013-2018)
Figure Genentech, Inc. Chronic Urticaria Or Hives Drug Revenue Market Share in EMEA (2013-2018)
Table GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Basic Information List
Table GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Sales Market Share in EMEA (2013-2018)
Figure GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Revenue Market Share in EMEA (2013-2018)
Table J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Basic Information List
Table J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Sales Market Share in EMEA (2013-2018)
Figure J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Revenue Market Share in EMEA (2013-2018)
Table Mabtech Limited Chronic Urticaria Or Hives Drug Basic Information List
Table Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Mabtech Limited Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Mabtech Limited Chronic Urticaria Or Hives Drug Sales Market Share in EMEA (2013-2018)
Figure Mabtech Limited Chronic Urticaria Or Hives Drug Revenue Market Share in EMEA (2013-2018)
Table Merck & Co., Inc. Chronic Urticaria Or Hives Drug Basic Information List
Table Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Merck & Co., Inc. Chronic Urticaria Or Hives Drug Sales Market Share in EMEA (2013-2018)
Figure Merck & Co., Inc. Chronic Urticaria Or Hives Drug Revenue Market Share in EMEA (2013-2018)
Table Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Basic Information List
Table Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Sales Market Share in EMEA (2013-2018)
Figure Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Revenue Market Share in EMEA (2013-2018)
Table Novartis AG Chronic Urticaria Or Hives Drug Basic Information List
Table Panacea Biotec Limited Chronic Urticaria Or Hives Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chronic Urticaria Or Hives Drug
Figure Manufacturing Process Analysis of Chronic Urticaria Or Hives Drug
Figure Chronic Urticaria Or Hives Drug Industrial Chain Analysis
Table Raw Materials Sources of Chronic Urticaria Or Hives Drug Major Manufacturers in 2017
Table Major Buyers of Chronic Urticaria Or Hives Drug
Table Distributors/Traders List
Figure EMEA Chronic Urticaria Or Hives Drug Sales (K Pcs) and Growth Rate Forecast (2018-2025)
Figure EMEA Chronic Urticaria Or Hives Drug Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Chronic Urticaria Or Hives Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
Table EMEA Chronic Urticaria Or Hives Drug Sales (K Pcs) Forecast by Region (2018-2025)
Figure EMEA Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Region (2018-2025)
Table EMEA Chronic Urticaria Or Hives Drug Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Chronic Urticaria Or Hives Drug Revenue Market Share Forecast by Region (2018-2025)
Table Europe Chronic Urticaria Or Hives Drug Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Europe Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Countries (2018-2025)
Table Europe Chronic Urticaria Or Hives Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Chronic Urticaria Or Hives Drug Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Chronic Urticaria Or Hives Drug Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Middle East Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Chronic Urticaria Or Hives Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Chronic Urticaria Or Hives Drug Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Chronic Urticaria Or Hives Drug Sales (K Pcs) Forecast by Countries (2018-2025)
Figure Africa Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Countries (2018-2025)
Table Africa Chronic Urticaria Or Hives Drug Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Chronic Urticaria Or Hives Drug Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Chronic Urticaria Or Hives Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure EMEA Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Type (2018-2025)
Table EMEA Chronic Urticaria Or Hives Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure EMEA Chronic Urticaria Or Hives Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources